Drug Shortage Report for TEVA-LISINOPRIL/HCTZ (TYPE Z)
| Report ID | 97625 |
| Drug Identification Number | 02301776 |
| Brand name | TEVA-LISINOPRIL/HCTZ (TYPE Z) |
| Common or Proper name | LISINOPRIL/HCTZ Z |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE LISINOPRIL |
| Strength(s) | 12.5MG 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30's & 100's |
| ATC code | C09BA |
| ATC description | ACE INHIBITORS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-11-01 |
| Actual start date | 2020-04-01 |
| Estimated end date | 2020-09-30 |
| Actual end date | 2020-09-23 |
| Shortage status | Resolved |
| Updated date | 2020-09-24 |
| Company comments | Will cover 25% of the market throughout shortage period. Due to competitor shortage. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2019-11-02 | English | Compare |
| v2 | 2019-10-31 | French | Compare |
| v1 | 2019-10-31 | English | Compare |